Marksans Pharma Limited has announced the closure of its trading window for designated persons and their immediate relatives. This closure will be effective from Thursday, January 01, 2026. The trading window will remain closed until 48 hours after the declaration of the unaudited financial results for the quarter ending December 31, 2025. The specific date for the declaration of these financial results will be communicated separately. During this period, designated persons and their relatives are prohibited from trading in the company's shares. This measure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct.